New York Times stunningly rolls back claims about viral photo of…
“This additional detail gives readers a greater understanding of his situation.”
Related Articles
Management recommendations for kidney transplantation in patients with plasma cell dyscrasia
Patients with plasma cell dyscrasias (PCD), including multiple myeloma, AL amyloidosis, and monoclonal gammopathy of renal significance (MGRS), face a high burden of end-stage kidney…
Life’s Too Short for Bad Olive Oil – The Wirecutter Show | iHeart
This episode, senior kitchen writer Michael Sullivan demystifies all things olive oil. He shares how to navigate the overwhelming olive oil aisle, what “extra virgin”…
Lyme Disease Surges in Michigan: 2025 Tick Boom
Lyme disease is spiking across Michigan. Discover why ticks are thriving—and simple steps to avoid them.
Breakthrough blood test offers earlier and more accurate heart disease detection
A new study finds that measuring apoB particles in the blood predicts heart disease risk more accurately than standard cholesterol tests.
Liso-cel Effective for 2nd-Line LBCL- SOHO Insider
Liso-cel shows durable responses in R/R LBCL patients not for HSCT, per PILOT study in Blood Advances. Explore findings now!
Pirtobrutinib Outperforms Investigators’ Choice Treatment in Relapsed or Refractory CLL and SLL | Blood Cancers Today
Pirtobrutinib demonstrated a superior PFS of 14 months in patients with relapsed or refractory CLL or SLL, compared with 8.7 months with investigator’s choice.
Heart Failure in Practice: What and How
The heart failure landscape is advancing rapidly. This issue of JACC features a collection of papers that reflect this momentum. They examine therapy efficacy and…
FDA Approves Pegcetacoplan for C3G and IC-MPGN | Docwire News
The FDA approved pegcetacoplan for treating C3 glomerulopathy (C3G) and primary immune complex membranoproliferative glomerulonephritis (IC-MPGN in patients age 12 and older.
The Antifibrotic Effects of Eplerenone in Hypertrophic Cardiomyopathy: A Randomized Clinical Trial
AbstractBackgroundFibrosis plays a central role in hypertrophic cardiomyopathy (HCM), contributing to symptoms via impaired systolic and diastolic function and ventricular arrhythmias.ObjectivesThe…